These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 26781914

  • 1. High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.
    Grote Beverborg N, van der Wal HH, Klip IT, Voors AA, de Boer RA, van Gilst WH, van Veldhuisen DJ, Gansevoort RT, Hillege HL, van der Harst P, Bakker SJ, van der Meer P.
    Eur J Heart Fail; 2016 Jul; 18(7):814-21. PubMed ID: 26781914
    [Abstract] [Full Text] [Related]

  • 2. Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community.
    Klip IT, Voors AA, Swinkels DW, Bakker SJ, Kootstra-Ros JE, Lam CS, van der Harst P, van Veldhuisen DJ, van der Meer P.
    Eur J Heart Fail; 2017 Mar; 19(3):348-356. PubMed ID: 27758018
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Nagai T, Nishimura K, Honma T, Higashiyama A, Sugano Y, Nakai M, Honda S, Iwakami N, Okada A, Kawakami S, Kanaya T, Asaumi Y, Aiba T, Nishida Y, Kubota Y, Sugiyama D, Okamura T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T, NaDEF investigators.
    Eur J Heart Fail; 2016 Jul; 18(7):803-13. PubMed ID: 27126377
    [Abstract] [Full Text] [Related]

  • 4. Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study.
    Garimella PS, Katz R, Patel KV, Kritchevsky SB, Parikh CR, Ix JH, Fried LF, Newman AB, Shlipak MG, Harris TB, Sarnak MJ, Health ABC Study.
    Circ Heart Fail; 2016 Jan; 9(1):e002124. PubMed ID: 26721912
    [Abstract] [Full Text] [Related]

  • 5. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF, De Jong MA, Van der Meer P, Leaf DE, Huls G, Nolte IM, Gaillard CAJM, Bakker SJL, De Borst MH.
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [Abstract] [Full Text] [Related]

  • 6. Non-hemodynamically significant renal artery stenosis predicts cardiovascular events in persons with ischemic heart disease.
    Zanoli L, Rastelli S, Marcantoni C, Capodanno D, Blanco J, Tamburino C, Laurent S, Boutouyrie P, Castellino P.
    Am J Nephrol; 2014 Jun; 40(5):468-77. PubMed ID: 25503847
    [Abstract] [Full Text] [Related]

  • 7. Inflammation and anaemia in a broad spectrum of patients with heart failure.
    Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, van Veldhuisen DJ, van der Meer P.
    Heart; 2012 Aug; 98(16):1237-41. PubMed ID: 22730482
    [Abstract] [Full Text] [Related]

  • 8. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC, Chang TI, Mitani AA, Wilhelm-Leen ER, Ding V, Chertow GM, Brookhart MA, Goldstein BA.
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [Abstract] [Full Text] [Related]

  • 9. Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
    Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, Barany P, Ärnlöv J, Carrero JJ, Matsushita K.
    J Am Heart Assoc; 2019 Apr 16; 8(8):e010546. PubMed ID: 30947615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
    Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators.
    JAMA; 2001 Jul 25; 286(4):421-6. PubMed ID: 11466120
    [Abstract] [Full Text] [Related]

  • 12. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
    Sposato LA, Lam M, Allen B, Shariff SZ, Saposnik G, PARADISE Study Group.
    Stroke; 2020 Feb 25; 51(2):387-394. PubMed ID: 31914883
    [Abstract] [Full Text] [Related]

  • 13. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals.
    Tanaka F, Komi R, Makita S, Onoda T, Tanno K, Ohsawa M, Itai K, Sakata K, Omama S, Yoshida Y, Ogasawara K, Ishibashi Y, Kuribayashi T, Okayama A, Nakamura M, Iwate-Kenco Study Group.
    J Hypertens; 2016 Mar 25; 34(3):506-12; discussion 512. PubMed ID: 26820477
    [Abstract] [Full Text] [Related]

  • 14. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M.
    J Am Coll Cardiol; 2015 Sep 01; 66(9):1000-7. PubMed ID: 26314526
    [Abstract] [Full Text] [Related]

  • 15. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.
    JAMA; 2005 Apr 06; 293(13):1609-16. PubMed ID: 15811980
    [Abstract] [Full Text] [Related]

  • 16. Endogenous erythropoietin and outcome in heart failure.
    Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ.
    Circulation; 2010 Jan 19; 121(2):245-51. PubMed ID: 20048213
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ, PREVEND IT Study Group.
    Clin Ther; 2006 Mar 19; 28(3):432-44. PubMed ID: 16750458
    [Abstract] [Full Text] [Related]

  • 18. Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin.
    Calvin AD, Somers VK, Steensma DP, Rio Perez JA, van der Walt C, Fitz-Gibbon JM, Scott CG, Olson LJ.
    Eur J Heart Fail; 2010 Apr 19; 12(4):354-9. PubMed ID: 20335353
    [Abstract] [Full Text] [Related]

  • 19. Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study.
    Fangel MV, Nielsen PB, Kristensen JK, Larsen TB, Overvad TF, Lip GY, Jensen MB.
    Am J Med; 2020 Jun 19; 133(6):e269-e279. PubMed ID: 32205071
    [Abstract] [Full Text] [Related]

  • 20. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
    Leitão L, Soares-Dos-Reis R, Neves JS, Baptista RB, Bigotte Vieira M, Mc Causland FR.
    Stroke; 2019 Dec 19; 50(12):3639-3642. PubMed ID: 31637971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.